FDA Warning Letter — Genovate
The FDA took a Warning Letter action against Genovate on Jan 8, 2026 (Blaine, WA). The action was issued by CBER and concerns biologics products.
Action Details
- Facility
- Genovate
- Date
- Jan 8, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Center
- CBER
- Location
- Blaine, WA (United States)